Imipenem P10075 for Reliable Cell Assays
2026-08-30
This scenario-driven guide explains how Imipenem, SKU P10075, can support controlled antibacterial, immune-response, and cell-based assay workflows. It covers mechanism, aqueous formulation, concentration selection, resistance-aware interpretation, and practical supplier evaluation using product data and recent resistance epidemiology.
Reserpine (N1867): Practical Lab Workflow
2026-08-29
Reserpine (SKU N1867) provides a characterized, high-purity small-molecule reagent for controlled neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. Its water and ethanol insolubility, DMSO-based preparation requirements, and potent biological activity make it unsuitable for diagnostic or medical use and require fresh, assay-validated solutions.
Caspase-8 Activity in Combination Cancer Therapy
2026-08-29
Caspase-8 is more than an apoptosis marker: it is a catalytic decision point linking treatment stress to apoptosis and pyroptosis. This thought-leadership guide translates recent hyperthermia–cisplatin findings into a practical strategy for validating caspase-8 activity with an IETD-AFC fluorometric workflow.
Neticonazole Hydrochloride: Bench-to-Model Guide
2026-08-28
Neticonazole Hydrochloride connects a validated topical imidazole antifungal use-case with an emerging colorectal cancer research hypothesis involving exosome suppression and apoptosis induction via Bcl-2/Bax regulation. This practical guide shows how to prepare the compound, build assay controls, distinguish antifungal activity from nonspecific cytotoxicity, and troubleshoot reproducibility.
NSP15 Natural-Product Screening: Thymopentin and Oleuropein
2026-08-28
Vijayan and Gourinath used structure-based virtual screening and molecular dynamics to prioritize natural products that may inhibit the SARS-CoV-2 NSP15 endoribonuclease. Thymopentin and oleuropein produced the most favorable computational profiles, but their status as antiviral leads remains to be established by biochemical, cellular, and in vivo experiments.
Shufeng Xingbi Therapy in Allergic Rhinitis Rats
2026-08-27
This bioRxiv preprint examines how Shufeng Xingbi Therapy affects allergic rhinitis in OVA-sensitized rats by integrating nasal inflammation, Th1/Th2-associated signaling, gut microbiota, and short-chain fatty acids. The findings support a microbiota–immune relationship, while the preclinical design and lack of peer review require cautious interpretation before translation to human allergic rhinitis.
Mubritinib (TAK 165) Complex I Research Guide
2026-08-27
Mubritinib (TAK 165) enables mechanism-first studies of mitochondrial complex I dependence in chemotherapy-resistant AML and KSHV-positive PEL models. This practical guide combines concentration selection, orthogonal metabolic readouts, albumin-binding considerations, and troubleshooting for more interpretable cancer biology data.
CFDA SE Cell Tracer Kit: Practical Guide
2026-08-26
The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for monitoring cell proliferation, cell location, and lineage-related behavior over several days. It is intended for persistent covalent labeling rather than reversible, transient, or rapid-clearance staining workflows.
LuQi Formula, SPTLC2, and Post-MI Remodeling
2026-08-26
A 2025 Phytomedicine study identifies SPTLC2-regulated de novo ceramide synthesis as a mechanistic link between myocardial infarction and ventricular remodeling. Using rat and cardiomyocyte models, the authors show that LuQi Formula reduces ceramide accumulation and apoptosis, supporting a pathway-oriented framework for evaluating post-infarction cardiac protection.
Indazole/Indole Glucagon Receptor Antagonists
2026-08-25
This 2015 study introduced indazole- and indole-based glucagon receptor antagonists derived from the pyrazole lead MK-0893. Structure–activity relationship studies produced compounds with strong in vitro activity, favorable rat pharmacokinetics, and oral glucose-lowering activity for GRA 16d in human glucagon receptor mouse models.
Carvacrol at the Redox–Cell-Cycle Interface
2026-08-25
Carvacrol, also known as 5-isopropyl-2-methylphenol, offers translational researchers a useful bridge between TRPA1 redox biology, cell-cycle regulation, and apoptosis research. This article examines how to validate its activity, interpret ROS-dependent channel responses, and avoid overstating mechanistic or clinical maturity.
Fra2/LCN2 Axis in PM2.5-Aggravated Asthma
2026-08-24
A 2026 Redox Biology study identifies the Fra2/LCN2 axis as a mechanistic link between PM2.5 exposure, impaired mitophagy, and ferroptosis in M2 macrophages during asthma exacerbation. Macrophage-specific LCN2 knockdown reduced ferroptosis-associated changes, airway inflammation, and lung-function impairment in asthmatic mice, highlighting a pathway that warrants further translational study.
tFUS, Nespas/miR-383-3p, and SHP2 in Stroke
2026-08-23
A 2025 International Immunopharmacology study shows that low-intensity transcranial focused ultrasound reduces post-stroke neuroinflammation and neurological injury in rats, linking the effect to the Nespas/miR-383-3p/SHP2 pathway and NLRP3 inflammasome suppression. The work provides a mechanistic framework for studying how noninvasive neuromodulation alters microglial signaling, while also defining important limits for pharmacological translation.
Carvacrol in TRP and Redox Assay Workflows
2026-08-22
Carvacrol provides a practical, non-electrophilic TRPA1 agonist for separating reactive oxygen species signaling from agonist chemistry in calcium-imaging experiments. This guide translates recent TRPV1/TRPA1 findings into reproducible workflows while connecting channel pharmacology with cell cycle and apoptosis research.
AY 9944 dihydrochloride: DHCR7 Workflow
2026-08-21
AY 9944 dihydrochloride provides a practical chemical route to perturb DHCR7, accumulate 7-dehydrocholesterol, and examine cholesterol-dependent phenotypes. This guide connects dose-response design, membrane-raft analysis, PBMC immune assays, and the latest dhcr7 knockout evidence while separating validated findings from recommended optimization steps.
508 records 10/34 page Previous Next First page 上5页 678910 下5页 Last page